| Financial Year |
March 31 2023 |
| Monetary Funds |
6,603,863,501.16 |
| Held-for-trading Financial Assets |
926,032,823.74 |
| Notes Receivable |
54,244,764.41 |
| Accounts Receivable |
2,159,326,023.95 |
| Advances to Suppliers |
114,388,836.99 |
| Other Receivables |
222,185,607.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,398,275.00 |
| Inventories |
2,367,265,628.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
920,533,173.43 |
| Total Current Assets |
13,537,295,190.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,463,372.94 |
| Long-term Equity Investment |
976,240,439.49 |
| Investment Properties |
141,382,109.73 |
| Fixed Assetes |
1,439,831,109.08 |
| Under-construction Projects |
354,371,461.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
173,036,178.78 |
| R&D expenses |
-- |
| Goodwill |
827,156,916.84 |
| Long-Term Deferred and Prepaid Expenses |
25,712,421.52 |
| Deferred Income Tax Assets |
232,449,660.40 |
| Other Non-Current Assets |
1,408,660,008.35 |
| Sub-Total of Non-Current Assets |
6,340,061,749.91 |
| Total Assets |
19,877,356,940.82 |
| Short-Term Loans |
131,248,722.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,502,611,443.70 |
| Accounts Payable |
927,543,496.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
471,872,022.34 |
| Taxes Payable |
94,027,878.01 |
| Interest Payable |
-- |
| Dividend Payable |
1,860,000.00 |
| Other payables |
321,774,576.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,604,795.63 |
| Other Current Liabilities |
58,681,986.86 |
| Sub-Total of Current Liabilities |
5,770,955,417.19 |
| Long-term Loans |
309,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,170,308.96 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
463,997,324.45 |
| Total Liabilities |
6,234,952,741.64 |
| Paid-In Capital(Or Share Stock) |
2,483,382,898.00 |
| Capital Surplus |
3,003,609,032.89 |
| Surplus Reserve |
747,114,058.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,819,520,849.12 |
| Minority Stockholder's Interest |
1,829,056,949.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,813,347,250.16 |
| Owner's Equity（Stockholder's Equity） |
13,642,404,199.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,877,356,940.82 |
